Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Research

• Publication date

  2013-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1538-7445.AM2013-1515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPβ protein synthesis in colorectal adenomas

  2026cites this paper
• Post-Treatment Tumor Immune Microenvironment and the Dual Role of Myeloid-Derived Suppressor Cells (MDSCs) in Cancer Progression and Therapeutic Resistance.

  2026cites this paper
• Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

  2026cites this paper
• The Issue on Dualistic Role of Neutrophils in Carcinogenesis and Their Possible Use for Treatment of Malignant Neoplasms

  2025cites this paper
• Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy

  2025cites this paper
• Unraveling the Complexities of Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease

  2025cites this paper
• Multifaceted role of myeloid-derived suppressor cells in colorectal cancer.

  2025cites this paper
• Increasing RB1 Expression by Targeting EZH2 in Triple‐Negative Breast Cancer

  2025cites this paper
• MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors.

  2025cites this paper
• Histone acetylation modulators in breast cancer

  2025cites this paper
• Modulating phosphodiesterase-5 activity to suppress the immunosuppressive mechanisms of myeloid-derived suppressor cells in breast cancer

  2025cites this paper
• The epigenetic hallmarks of immune cells in cancer

  2025cites this paper
• New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma

  2025cites this paper
• Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment

  2025cites this paper
• Effects of different hypoxia exposure on myeloid-derived suppressor cells in mice.

  2024cites this paper
• The crude alkaloidal extract of Picralima nitida seeds alleviates TNBS-induced inflammatory bowel disease through reduced serum expression of TNF-α, IL-1β and p38 MAPK

  2024cites this paper
• Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer.

  2024cites this paper
• The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis

  2024cites this paper
• Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy

  2024cites this paper
• Protocol to study the immune profile of syngeneic mouse tumor models

  2024cites this paper
• Exploring the Potential of Glycolytic Modulation in Myeloid-Derived Suppressor Cells for Immunotherapy and Disease Management

  2024cites this paper
• The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer

  2024cites this paper
• Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer

  2024cites this paper
• Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer

  2024cites this paper
• MDSC expansion during HIV infection: regulators, ART and immune reconstitution

  2024cites this paper
• PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC

  2024cites this paper
• High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP

  2024cites this paper
• In vitro production of myeloid-derived suppressor cells from peripheral blood monocytes

  2023cites this paper
• Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies

  2023cites this paper
• CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells

  2023cites this paper
• Dabrafenib alters MDSC differentiation and function by activation of GCN2

  2023cites this paper
• Myeloid‐derived suppressor cells in the therapy of autoimmune diseases

  2023cites this paper
• Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells.

  2023cites this paper
• Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies

  2023influential citation
• Tumor-associated myeloid cells in cancer immunotherapy

  2023cites this paper
• The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers

  2023cites this paper
• Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities

  2023cites this paper
• Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities

  2023cites this paper
• The emerging era of lactate: A rising star in cellular signaling and its regulatory mechanisms

  2023cites this paper
• Defining and targeting tumor-associated macrophages in malignant mesothelioma

  2023cites this paper
• Краткие сообщения Short

  2023cites this paper
• Epigenetic programming of the immune responses in cancer

  2022cites this paper
• Tumor-Associated Macrophages and Related Myelomonocytic Cells in the Tumor Microenvironment of Multiple Myeloma

  2022cites this paper
• C/EBPβ enhances immunosuppression activity of myeloid-derived suppressor cells by a P300-mediated acetylation modification

  2022influential citation
• Myeloid-derived suppressor cell: A crucial player in autoimmune diseases

  2022cites this paper
• Epigenetic modifications in the accumulation and function of myeloid-derived suppressor cells

  2022cites this paper
• Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.

  2022cites this paper
• Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke

  2022cites this paper
• Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin

  2022cites this paper
• Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism

  2022cites this paper
• Flow cytometry-based Immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samples.

  2022cites this paper
• Granulocyte Colony-Stimulating Factor Accelerates the Recovery of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure by Promoting M2-Like Transition of Monocytes

  2022cites this paper
• Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils

  2022cites this paper
• MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.

  2022cites this paper
• Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment

  2022cites this paper
• Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy

  2022cites this paper
• The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.

  2022cites this paper
• Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy

  2022influential citation
• New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19

  2022cites this paper
• Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity

  2022cites this paper
• CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor

  2022cites this paper
• Chlamydia pneumoniae Interferes with Macrophage Differentiation and Cell Cycle Regulation to Promote Its Replication

  2022cites this paper
• Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-Jun axis.

  2022cites this paper
• Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets

  2022cites this paper
• Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes

  2021cites this paper
• The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies

  2021cites this paper
• A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment

  2021cites this paper
• The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis.

  2021cites this paper
• Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells.

  2021cites this paper
• Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases

  2021cites this paper
• Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

  2021cites this paper
• Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

  2021cites this paper
• Myeloid-Derived Suppressor Cells

  2021cites this paper
• Myeloid-derived suppressor cells (MDSC): When good intentions go awry.

  2021cites this paper
• Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression

  2021cites this paper
• Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression

  2021cites this paper
• Myeloid-Derived Suppressor Cell Differentiation in Cancer: Transcriptional Regulators and Enhanceosome-Mediated Mechanisms

  2021influential citation
• Chronic restraint stress promotes the mobilization and recruitment of myeloid‐derived suppressor cells through β‐adrenergic‐activated CXCL5‐CXCR2‐Erk signaling cascades

  2021cites this paper
• Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy

  2021cites this paper
• Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

  2021cites this paper
• High-Dimensional Phenotyping of Human Myeloid-Derived Suppressor Cells/Tumor-Associated Macrophages in Tissue by Mass Cytometry.

  2021cites this paper
• Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

  2021cites this paper
• Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.

  2021cites this paper
• Cancer epigenetics: past, present and future.

  2021cites this paper
• Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy

  2021cites this paper
• Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy

  2020cites this paper
• p110δ PI3K as a therapeutic target of solid tumours.

  2020cites this paper
• The Immunology of Sepsis – Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment

  2020cites this paper
• Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling

  2020cites this paper
• Rational targeting of immunosuppressive neutrophils in cancer.

  2020cites this paper
• Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

  2020cites this paper
• Effects of Hypertonic Saline and Hydroxyethyl Starch on Myeloid-Derived Suppressor Cells in Hemorrhagic Shock Mice under Secondary Bacterial Attack

  2020cites this paper
• A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche

  2020cites this paper
• Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy.

  2020cites this paper
• LncRNA AK036396 Inhibits Maturation and Accelerates Immunosuppression of Polymorphonuclear Myeloid–Derived Suppressor Cells by Enhancing the Stability of Ficolin B

  2020cites this paper
• Epigenetic therapy inhibits metastases by disrupting premetastatic niches

  2020cites this paper
• Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression

  2020cites this paper
• The Engagement Between MDSCs and Metastases: Partners in Crime

  2020cites this paper
• Differentiation of c‐Kit+CD24+ natural killer cells into myeloid cells in a GATA‐2‐dependent manner

  2020cites this paper
• HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma

  2020cites this paper